Battling antibiotic resistance by stopping evolution

mrsa in petri dish

One of the ways that bacteria evolve to become “antibiotic resistant” is by picking up free-floating genetic material from their environments. They then incorporate the scavenged genes into their own DNA. In this way, bacteria can collect genes shed from microbes that are already resistant, and thus, gain resistance themselves. But bacteria aren’t able to catch wayward bits of DNA without the right equipment; the “bugs” must first enter a state called “competence” to build the machinery required to scoop genetic material from their surroundings.

Studies suggest that several common classes of antibiotics actually drive the spread of antibiotic resistance by pushing bacteria into a stressed-out state. But now, a new study of the bacteria Streptococcus pneumoniae has highlighted a potential solution to this paradoxical problem: drugs that prevent bacteria from becoming competent in the first place.

For the study, published [March 3] in the journal Cell Host & Microbe, researchers put this strategy to the test in a mouse model and successfully blocked several strains of S. pneumoniae from becoming competent and exchanging genes inside the mice.

Future studies will be needed to determine whether “‘anti-evolution’ drugs can be realistically used in combination with antibiotics to prevent the spread of antibiotic resistance,” the authors noted in their paper.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-09-17 at 12.41
Misinformation alert: No, glyphosate use in Canadian forests is not spurring more wildfires
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jul-7-2026-01_57_55-PM
Viewpoint: Europe’s rejection of air conditioning is the poster child for misunderstanding how to mitigate the impact of climate change
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
ChatGPT-Image-Jul-1-2026-03_33_49-PM
‘Alternative’ cancer treatments that could kill you
ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
ChatGPT-Image-Jun-17-2026-03_29_08-PM
Viewpoint: What’s the impact of the U.S. abandoning support for global health?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.